Home Treatment of HIV-Infected Patients With Interleukin-2 With or Without a Tumor Necrosis Factor Antagonist

NCT00001475 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

85

Enrollment

NIH

Sponsor class

Conditions

Acquired Immunodeficiency Syndrome
HIV Infection

Interventions

DRUG: IL-2 plus Anti-TNF or Thalidomide

Sponsor

National Institute of Allergy and Infectious Diseases (NIAID)